TRU-SENTIMENT · DeltaNeutral
ACAD Trading Analysis - 09/23/2026 02:28 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ACAD (Acadia Pharmaceuticals Inc.) at $25.08. True Sentiment Bullish, delta 40-60 call 87% / put 13%, call $36,145 vs put $5,360. RSI 19.2.
- Symbol
- ACAD
- Price
- $25.08
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-09-23 14:28:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Options flow sentiment is bullish, with a call dollar volume of $36,145 and a put dollar volume of $5,360.
The conviction is strongly bullish, suggesting near-term expectations of a price increase.
Key Statistics: ACAD
Fundamental Snapshot
Valuation
| P/E (Trailing) | 11.84 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 6.96 |
Profitability
| EPS (Trailing) | $2.23 |
| EPS (Forward) | N/A |
| ROE | 29.12% |
| Net Margin | 33.42% |
Financial Health
| Revenue (TTM) | $1.14B |
| Debt/Equity | 0.33 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for ACAD include:
- ACADIA Pharmaceuticals announces FDA approval for a new treatment.
- The company reports increased sales for its flagship product.
- Analysts upgrade ACAD's rating due to strong financials.
These headlines suggest positive developments for ACAD, potentially impacting its stock price. The FDA approval and increased sales could be significant catalysts, while the analyst upgrade adds to the positive sentiment.
Fundamental Analysis:
Based on the provided fundamentals:
- Revenue: $1,138,643,000
- Trailing EPS: $2.23
- Trailing P/E: 11.84
- Price-to-Book: 6.96
- Debt-to-Equity: 0.33
- Return on Equity (ROE): 29.12%
- Gross Margin: 91.13%
- Operating Margin: 7.59%
- Profit Margin: 33.42%
The company shows strong profitability with high gross and profit margins. The P/E ratio suggests a relatively fair valuation. However, the debt-to-equity ratio is low, indicating a healthy balance sheet.
Current Market Position:
Current price: $25.08
Recent price action shows a decline, with the stock reaching a low of $24.93.
Technical Analysis:
Technical Indicators
The RSI indicates oversold conditions, while the MACD shows a bearish signal. The 50-day SMA is above the current price, indicating a downtrend.
True Sentiment Analysis (Delta 40-60 Options):
Options flow sentiment is bullish, with a call dollar volume of $36,145 and a put dollar volume of $5,360.
The conviction is strongly bullish, suggesting near-term expectations of a price increase.
Key Price Levels (observational only):
Support level: $24.93 (recent low), Resistance level: $27.62 (50-day SMA).
25-Day Price Forecast:
ACAD is projected for $23.50 to $26.50 in 25 days.
The forecast is based on current technical trends, momentum, and indicators, including the SMA trends, RSI momentum, MACD signals, and recent volatility (ATR).
Defined Risk Strategy Recommendations:
Based on the price forecast:
- Buy Bull Call Spread: ACAD 261016C00025000 (strike $25.0) and sell ACAD 261016C00026000 (strike $26.0).
- Sell Bear Put Spread: ACAD 261016P00024000 (strike $24.0) and buy ACAD 261016P00023000 (strike $23.0).
- Buy Iron Condor: Sell ACAD 261016C00025000 (strike $25.0) and buy ACAD 261016C00026000 (strike $26.0), sell ACAD 261016P00024000 (strike $24.0) and buy ACAD 261016P00023000 (strike $23.0).
These strategies align with the projected price range and offer defined risk.
Risk Factors:
- Technical warning signs: RSI oversold conditions.
- Sentiment divergences: bullish options flow vs bearish technicals.
- Volatility and ATR considerations: recent price decline.
These factors could impact the stock price and trading strategies.
Summary & Conviction Level:
Overall bias: bearish.
Conviction level: medium.
One-line trade idea: Consider defined risk strategies based on technical and sentiment analysis.
View ACAD Options Chain